PepGen Ltd (PEPG : NASDAQ)
Common Stock
Follow PEPG
PEPG
PepGen Ltd
WealthAwesomePerformance
1 Day
+92.89%
1 Week
+87.40%
1 Month
+75.95%
YTD
+171.18%
The Saturday TSX Wrap · free, every saturday morning. The week on the TSX, in five minutes.
Key Statistics
Market Cap
$165.31M
52W High
$7.80
52W Low
$1.31
P/E Ratio
-
50 Day MA
$2.66
200 Day MA
$2.94
Beta
2.02
Dividend Yield
-
Performance history
PEPG returns since 2026
PepGen Ltd has traded since Jun 2026 in our data. Its deepest fall was −35.5% (Aug 2026 to Oct 2026).
1 year / yr
—
3 years / yr
—
5 years / yr
—
10 years / yr
—
Calendar-year returns
- 2026*+171.2%
* Partial year (first year of data, or year to date).
$10,000 invested in PEPG
- 2026 (start of our data)$27,118
- All-time high in our data
- $5 on Nov 10, 2026 · at the high
Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Jun 2026 to Nov 2026. Past returns do not predict future ones.
Awesome Portfolio™
Looking past PEPG? Our 10 best Canadian stocks, in one list.
14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/10/2026 | $5.54 | $6.45 | $4.42 | $4.61 | $4.61 | 104,419,994 |
| 11/9/2026 | $2.52 | $2.52 | $2.28 | $2.39 | $2.39 | 1,364,768 |
| 11/6/2026 | $2.33 | $2.52 | $2.33 | $2.47 | $2.47 | 998,200 |
| 11/5/2026 | $2.55 | $2.55 | $2.22 | $2.32 | $2.32 | 958,704 |
| 11/4/2026 | $2.53 | $2.69 | $2.38 | $2.45 | $2.45 | 1,800,600 |
| 11/3/2026 | $2.36 | $2.48 | $2.36 | $2.46 | $2.46 | 612,496 |
| 11/2/2026 | $2.39 | $2.47 | $2.31 | $2.35 | $2.35 | 565,863 |
| 10/30/2026 | $2.40 | $2.40 | $2.22 | $2.36 | $2.36 | 1,129,000 |
| 10/29/2026 | $2.54 | $2.62 | $2.40 | $2.41 | $2.41 | 766,432 |
| 10/28/2026 | $2.58 | $2.64 | $2.48 | $2.53 | $2.53 | 767,793 |
Analyst Price Targets
Based on 8 analysts covering PEPG · as of Oct 5, 2026
Wall Street analysts forecast PEPG stock price to rise 121.0% over the next 12 months.
Consensus
Strong Buy4.63 / 5.00
Avg. Target
US$10.19
+121.0% Upside
Current Price
US$4.61
Last close
Analyst Breakdown (8 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PEPG's historical volatility
30-Day Vol
205.1%
Annualized
90-Day Vol
139.6%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$5.51
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$4.89 | US$2.41 – US$9.93 |
| 60 trading days | US$5.19 | US$1.91 – US$14.12 |
| 90 trading days | US$5.51 | US$1.62 – US$18.77 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About PepGen Ltd
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study. The company was founded in 2018 and is based in Boston, Massachusetts.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-74.99M
- Profit Margin
- 0.00%
- ROE (TTM)
- -75.45%
- EPS (Diluted)
- -1.01
- Book Value
- 1.73
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Free newsletter
The Saturday TSX Wrap
The week on the TSX, in five minutes
- The biggest gainers and losers, and why they moved
- Sector and momentum moves at a glance
- The Canadian market stories you missed
Explore More
Common Questions About PEPG.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| SMX | SMX (Security Matters) Public Limited Company Class A Ordinary Shares | $19.25 | +105.88% |
| TTEC | TTEC Holdings Inc | $2.40 | +72.04% |
| NNOX | Nano X Imaging Ltd | $0.37 | +59.80% |
| TANH | Tantech Holdings Ltd | $30.56 | +58.01% |
| AACG | ATA Creativity Global | $0.89 | +52.14% |
| ESLA | Estrella Immunopharma Inc. | $0.75 | +45.40% |
| MNDO | MIND CTI Ltd | $1.26 | +44.83% |
| LGVN | Longeveron LLC | $2.84 | +41.29% |
Latest PEPG news
Wire stories from the last 10 days. Links open the original publisher.
- PepGen launches $125M stock offering to support clinical development
seekingalpha.com · 15h ago
- PepGen climbs 100% as BofA upgrades on new mid-stage trial data for lead asset
seekingalpha.com · 17h ago
- PepGen Stock Spikes 132% on Rare-Disease Win. These Rivals Are Feeling The Pressure.
Yahoo Finance · 18h ago
- PepGen Stock Doubles in One Session - Here's Why
Yahoo Finance · 18h ago